Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Extract of Dioscorea sp. and the medical uses thereof

Inactive Publication Date: 2006-03-30
NATIONAL YANG MING UNIVERSITY
View PDF13 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0007] The present invention provides a method for treating osteoporosis in a subject in need of such treatment, comprising administering orally to the subject an effective amount of an extract product of a Dioscorea species capable of promoting proliferation and differentiation of bone marrow cells in the subject, wherein the Dioscorea species is characterized by a RAPD fingerprint comprising at least 14 DNA bands ranging from 428 bp, 452 bp, 537 bp, 602 bp, 723 bp, 817 bp, 934 bp, 1140 bp, 1242 bp, 1478 bp,

Problems solved by technology

However, these studies were only conducted on old people taking diosgenin present in the Dioscorea to investigate if diosgenin could reduce the over-oxidation of serum lipids, lower the triglycerides in blood serum and increase high density level (HDL) of cholesterol while decreasing the over-oxidation damage of low density level (LDL) of cholesterol.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extract of Dioscorea sp. and the medical uses thereof
  • Extract of Dioscorea sp. and the medical uses thereof
  • Extract of Dioscorea sp. and the medical uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

The Proliferative Response of Osteoprogenitor Cells of Mice Treated with the Methanol Extract and the Further Extracted Fractions of Dioscorea sp.

[0053] The cells obtained in preparatory step 4 were dispersed using a 22 G gauge needle and suspended in DMEM / F12 medium containing 15% FCS, 50 μg / ml ascorbic acid, 10 mM sodium β-glycerophosphate and 10 nM dexamethazone to form a concentration of 4.5×104 cells / ml. 225 μl cell suspension was added into each well of a 96-well microplate. After 3 hours, to the cell suspension in each well was added 25 μl methanol extract, each of the further extracted fractions and DHEA and incubated for 72 hours. Then, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed. 1 mg / ml MTT solution was added in each well and reacted for 4 hours MTT lysis buffer (20% SDS-50% DMF) was added in each well in the amount of 150 μl / well and reacted for 16 hours, and the absorbance was measured at O.D. 570 nm for the resultant cell sus...

example 2

The Effect of the Methanol Extract and Different Extracted Fractions of Dioscorea sp on the Differentiation of Matured Osteoblastic Cells of Mice Determined by Alkaline Phosphatase Activity (ALP) In Vitro

[0055] Osteoprogenitor cells collected in preparatory step 4 were incubated in a T-flask for 6 days. The cells were dispersed with 22 G gauge needle, and the cell concentration was adjusted to 5×103 cell / cm2. The cells were then incubated in 6-well plates, in which 4.5 ml of cell culture medium was added in each well, and 0.5 ml methanol extract and each of the extracted fractions were added the next day. After incubation for 14 days, alkaline phosphatase activity assay was conducted thereon, as described below.

[0056] Drawing out the culture medium, the cell layer was washed several times with PBS. 0.5% Triton X-100 in PBS was added into each well. The resultant suspension was subjected to a freezing and thawing process at a temperature of 70° C. and 37° C., respectively. The trea...

example 3

The effects of the Methanol Extract Dioscorea sp on Alkaline Phosphatase (ALP) Activity of Bone Marrow Cells Derived from a Patient Suffering from Glucocorticoid-Induced Osteoporosis

[0058] The patient's bone marrow cells obtained from the Taipei Veterans General Hospital were cultured in DMEM / F12 medium containing 15% FCS, 50 μg / ml ascorbic acid, 10 mM sodium β-glycerophosphate and 10 nM dexamethasone for 7 days. Alkaline phosphatase activity assay was conducted thereon.

[0059] As shown in FIG. 3, expression of alkaline phosphatase was noted. Compared with the control group and positive group (1 nM estrogen, which is the known treatment for osteoporosis), the methanol extract of Dioscorea sp. increased the amount of the expressed alkaline phosphatase, in which the methanol extract at 10 μg / ml showed the strongest enhancement effect.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a method for treating osteoporosis in a subject in need of such treatment, including administering orally to the subject an effective amount of an extract product of a Dioscorea species capable of promoting proliferation and differentiation of bone marrow cells in the subject, wherein the Dioscorea species is characterized by a randomly amplified polymorphic DNA (RAPD) fingerprint including 14 DNA bands ranging from 428 bp, 452 bp, 537 bp, 602 bp, 723 bp, 817 bp, 934 bp, 1140 bp, 1242 bp, 1478 bp, 1641 bp, 1904 bp, 2151 bp and 2918 bp, respectively, when genomic DNA of the Dioscorea species is amplified with a primer of SEQ ID NO: 9, and the extract product is prepared by a process including the steps of: (a) extracting a tuber of the Dioscorea species using an alcohol-based solvent in the presence of acetic acid; (b) subjecting the resultant product obtained in step (a) to a separating treatment to obtain a soluble fraction; and (c) removing solvent from the soluble fraction obtained in step (b) extract fractions of Dioscorea sp.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] The present application is a continuation in part of application Ser. No. 10 / 335,278, filed on Dec. 31, 2002, which is hereby incorporated by reference herein in its entirety.BACKGROUND OF THE INVENTION [0002]Dioscorea, also known as “wild yam,” is a member of the monocotyledonous family Dioscoreaceae, which is distributed in the tropical and subtropical regions. There are about 650 species in the world, of which 93 species and 9 varieties are found in China, and 14 species and 5 varieties are found in Taiwan. [0003]Dioscorea is one of the very important pharmaceutical plants used in traditional Chinese medicine, and the medicinal effects thereof have been studied for years. In 1936, Tsukamoto et al isolated diosgenin, a steroid saponin of Dioscorea, from Dioscoreacea family of plants and then use it as raw material for rapid synthesis of medicinal steroids. In a study by Aradhana, Rao Ar, Kale R K. (Indian Journal of Experimental Biolo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8945A61K36/18A23L19/12A61P19/10A61P43/00
CPCA61K36/8945A61P19/10A61P43/00
Inventor WU, RONG-TSUN
Owner NATIONAL YANG MING UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com